Stock LLM Wiki

報告_MS_友達2409_20260730

更新 2026-07-31

PDF 原檔:報告_MS_友達2409_20260730_original.pdf

圖片清單(已驗證 2026-07-31)

檔名 size 分類 親眼所見內容
260730_ms_AUO_002.png 70KB 真資料圖 AUO 評等與目標價沿革圖(2023-07~2026-07 股價走勢,疊加歷次 E/I、U/I、O/I 評等變更標記與對應目標價數字,如 21、13.5、17、15、12.5、16.5、27)
260730_ms_AUO_001.png 66KB 裝飾·banner 「Asia Summer School 2026」游泳池廣告橫幅,非資料圖

原始內容

M July 30, 2026 04:57 PM GMT

AU Optronics | Asia Pacific

New Applications for Glass to Take Longer

AlphaSignals Earnings Reaction

Unchanged

Impact to our thesis

Source: Company data, Morgan Stanley Research

We don't see any strong catalysts from here with a lukewarm outlook for its core business and limited contributions from new applications. Stay EW.

3Q26 guidance below seasonal: Management guided for display revenue (48% of 2Q26 mix) to decline modestly QoQ as consumer electronics demand should be relatively soft amid elevated component costs and earlier restocking in 1H26. Mobility revenue (29% of 2Q26 mix) should remain roughly flat QoQ as Europe enters the slow season and China sees weakening demand. Vertical revenue (19% of 2Q26 mix) is expected to rise by low single digits % QoQ as orders from commercial displays and green solutions remain stable. We view 3Q26 guidance as below seasonal, although the revenue mix might turn a bit more favorable since the mobility and vertical business generated higher operating margins of 3.8% and 5.6%, respectively, vs. display at -3.2% in 2Q26. For the longer term, it maintains its target to have 70% of revenue from mobility and vertical solutions by 2030 (vs. 43% in 2025).

New business initiatives to take time : For glass in advanced packaging, AUO has been developing the TGV and RDL process for FOPLP and glass core. It is engaging with potential customers for LEO antenna modules and micro LED optical modules, which we think might see only limited revenue contribution in the coming years. Similar to its display supply chain peers, it is looking into the glass core substrate space and thinks it might take another 2-3 years for the process to mature. Mini/ micro LED is still on AUO's agenda for wearables and automobile applications. though we think the complexity in its process remains a big hurdle for this ultimate display technology to be commercialized in mainstream use cases. For CPO, it is in the designing and sampling process with one optical interconnect supplier, although we think it will take more time for AUO's integrated solution (micro LED + photodiode + glass substrate) to be adopted as the industry is still trying to sort out all of the issues in the current architecture.

More asset disposals : AUO announced plans to sell its Kaohsiung and Huaya fabs for expected gains of NT$4.28bn and NT$13.39bn, respectively; timing for recognition has not been finalized.

Stay EW: With a lackluster outlook for its core business and emerging businesses taking more time for contribution, we don't see any strong catalysts.

Modest upside

Financial results versus consensus

Modest revision higher

Direction of next 12-month consensus EPS

Update

Morgan Stanley Taiwan Limited+ Derrick Yang Equity Analyst Derrick.Yang@morganstanley.com +886 2 2730-2862
Vivi Huang Research Associate Vivi.Huang@morganstanley.com +886 2
Morgan Stanley Asia Limited+ Andy Meng, CFA Equity Analyst Andy.Meng@morganstanley.com 2730-2860 +852 2239-7689
260730_ms_AUO_001

AU Optronics (2409.TW, 2409 TT)

Greater China Technology Hardware | Taiwan

Stock Rating Equal-weight Equal-weight
Industry View In-Line
Price target NT$27.00
Up/downside to price target (%) Up/downside to price target (%) 22
Shr price, close (Jul 30, 2026) Shr price, close (Jul 30, 2026) NT$22.20
52-Week Range 52-Week Range NT$34.45-10.80
Sh out, dil, curr (mn) Sh out, dil, curr (mn) 7,571
Mkt cap, curr (mn) Mkt cap, curr (mn) NT$168,081
EV, curr (mn) EV, curr (mn) NT$226,747
Avg daily trading value (mn) Avg daily trading value (mn) NT$3,683 NT$3,683
Fiscal Year Ending 12/25 12/26e 12/27e 12/28e
EPS (NT$)** 0.90 (0.13) 0.21 0.43
EPS (NT$)§ 0.44 (0.10) 0.39 0.65
EBITDA (NT$ mn) 36,666 27,007 34,097 35,912
ModelWare net inc (NT 6,843 (997) 1,607 3,257
$ mn)
ROE (%) 4.5 (0.7) 1.1 2.2
EV/EBITDA 4.2 5.6 4.0 3.3
Div yld (%) 3.3 0.0 0.7 1.4

Unless otherwise noted, all metrics are based on Morgan Stanley ModelWare framework

** = Based on consensus methodology

§ = Consensus data is provided by Refinitiv Estimates

  • e = Morgan Stanley Research estimates

Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.

For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report.

+= Analysts employed by non-U.S. affiliates are not registered with FINRA, may not be associated persons of the member and may not be subject to FINRA restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.

M

Results Summary

Exhibit 1: AUO: Results summary

2Q26E Results 2Q26E Results 2Q26E Results
NT$mn Actual QoQ YoY MS estimates Variance Consensus Variance
Net sales 70,891 3% 2% 70,251 1% 69,809 2%
COGS -61,643 1% 3% -61,412 0% -61,245 1%
Gross profit 9,248 13% -1% 8,839 5% 8,564 8%
Operating expenses -9,030 2% 15% -8,992 0% -8,327 8%
Operating income 218 -134% -85% -153 -243% 238 -8%
Non-operating income 2,533 1787% 302% 230 1001% 236 971%
Pre-tax income 2,751 -649% 29% 77 3474% 474 480%
Net income 1,343 -217% -31% 65 1953% 356 278%
EPS (NT$) 0.18 -217% -31% 0.01 1953% 0.05 278%
Margins (%) ppt ppt ppt ppt
Gross margin 13.0% 1.2 -0.5 12.6% 0.5 12.3% 0.8
Operating margin 0.3% 1.2 -1.9 -0.2% 0.5 0.3% 0.0
Pre-tax margin 3.9% 4.6 0.8 0.1% 3.8 0.7% 3.2
Net margin 1.9% 3.6 -0.9 0.1% 1.8 0.5% 1.4

Source: Company data, Factset consensus, Morgan Stanley Research estimates

Earnings turnaround in 2Q26 : Off revenue of NT$70,891mn (+3% QoQ/+2% YoY), gross margin expanded by 1.2ppt to 13% on a more favorable product mix and improving operating efficiency. With the opex ratio flat QoQ at 12.7%, operating profit was NT $218mn, slightly better than MSe of a NT$153mn loss but in line with consensus of profit NT$238mn.

With a non-op gain of NT$2,533mn (mainly from asset disposal gain of ~NT$2.3bn), net income came in at NT$1,343mn (EPS NT$0.18), surpassing our expectation of NT$65mn (EPS NT$0.01) and consensus of NT$356mn (EPS NT$0.05).

M

Valuation Methodology and Risks

AU Optronics (2409.TW)

Base case, 2026e P/B of 1.4x. We believe price/book value better reflects AUO's intrinsic value, in view of the industry's relatively cyclical nature. The stock's mid-cycle average has been 0.8x P/B, but it has re-rated due to its CPO and LEO businesses. We see our target multiple as reasonable in consideration of the company's business diversification efforts, although they will take time to contribute.

Risks to Upside

  • n Stronger-than-expected end-demand
  • n Disciplined capacity control among peers
  • n Favorable panel pricing environment
  • n Faster progress on new business initiatives

Risks to Downside

  • n Macro headwinds leading to weak demand
  • n Faster yield improvement among Chinese players, leading to more supply
  • n Faster OLED panel adoption among large-size applications
  • n Slower progress on new business initiatives

M

Disclosure Section

The information and opinions in Morgan Stanley Research were prepared or are disseminated by Morgan Stanley Asia Limited (which accepts the responsibility for its contents) and/or Morgan Stanley Asia (Singapore) Pte. (Registration number 199206298Z) and/or Morgan Stanley Asia (Singapore) Securities Pte Ltd (Registration number 200008434H), regulated by the Monetary Authority of Singapore (which accepts legal responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research), and/or Morgan Stanley Taiwan Limited and/or Morgan Stanley & Co International plc, Seoul Branch, and/or Morgan Stanley Australia Limited (A.B.N. 67 003 734 576, holder of Australian financial services license No. 233742, which accepts responsibility for its contents), and/or Morgan Stanley Wealth Management Australia Pty Ltd (A.B.N. 19 009 145 555, holder of Australian financial services license No. 240813, which accepts responsibility for its contents), and/or Morgan Stanley India Company Private Limited having Corporate Identification No (CIN) U22990MH1998PTC115305, regulated by the Securities and Exchange Board of India ('SEBI') and holder of licenses as a Research Analyst (SEBI Registration No. INH000001105); Stock Broker (SEBI Stock Broker Registration No. INZ000244438), Merchant Banker (SEBI Registration No. INM000011203), and depository participant with National Securities Depository Limited (SEBI Registration No. IN-DP-NSDL-567-2021) having registered office at Altimus, Level 39 & 40, Pandurang Budhkar Marg, Worli, Mumbai 400018, India; Telephone no. +91-22-61181000; Compliance Officer Details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: tejarshi.hardas@morganstanley.com; Grievance officer details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: msic-compliance@morganstanley.com which accepts the responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research, and their affiliates (collectively, "Morgan Stanley"). Morgan Stanley India Company Private Limited (MSICPL) may use AI tools in providing research services. All recommendations contained herein are made by the duly qualified research analysts.

For important disclosures, stock price charts and equity rating histories regarding companies that are the subject of this report, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com/eqr/disclosures/webapp/generalresearch, or contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY, 10036 USA.

For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada +1 800 303-2495; Hong Kong +852 2848-5999; Latin America +1 718 754-5444 (U.S.); London +44 (0)20-7425-8169; Singapore +65 6834-6860; Sydney +61 (0)2-9770-1505; Tokyo +81 (0)3-6836-9000. Alternatively you may contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY 10036 USA.